Insiders Updates
Wolfe Research analysts upgrades a Peer perform rating for Alnylam Pharmaceuticals Inc (ALNY)
Alnylam Pharmaceuticals Inc’s recent filing unveils that its CSO & EVP, Head of Research Fitzgerald Kevin Joseph unloaded Company’s shares ...
Potential Price Increase for Dine Brands Global Inc (DIN) After Recent Insider Activity
Dine Brands Global Inc’s recent filing unveils that its Director Poulter Martha acquired Company’s shares for reported $21553.0 on Dec ...
Analyzing Five9 Inc (FIVN) After Recent Trading Activity
Five9 Inc’s recent filing unveils that its President Dignan Andy unloaded Company’s shares for reported $0.15 million on Dec 04 ...
DocuSign Inc [DOCU] Investment Appeal on the Rise
DocuSign Inc’s recent filing unveils that its Chief Revenue Officer Hansen Paula unloaded Company’s shares for reported $0.4 million on ...
Taking a Closer Look At Select Water Solutions Inc (WTTR) Following Its Recent Trade
Select Water Solutions Inc’s recent filing unveils that its President & CEO Schmitz John unloaded Company’s shares for reported $2.35 ...
The Potential Rise in the Price of Blue Owl Technology Finance Corp (OTF) following insiders activity
Blue Owl Technology Finance Corp’s recent filing unveils that its President Bissonnette Erik acquired Company’s shares for reported $0.17 million ...
Investing in Halliburton Co (HAL) Is Getting More Attractive
Halliburton Co’s recent filing unveils that its EVP and Chief Admin Officer Pope Lawrence J unloaded Company’s shares for reported ...
Antero Resources Corp’s latest rating changes from various analysts
Antero Resources Corp’s recent filing unveils that its insider Krueger Brendan E. acquired Company’s shares for reported $0.17 million on ...
Robert W. Baird gives a Neutral recommendation for Plymouth Industrial Reit Inc (PLYM)
Plymouth Industrial Reit Inc’s recent filing unveils that its EVP/Asset Management Connolly James unloaded Company’s shares for reported $1.3 million ...
Potential Price Increase for Immix Biopharma Inc (IMMX) After Recent Insider Activity
Immix Biopharma Inc’s recent filing unveils that its CEO and Chairman Rachman Ilya M acquired Company’s shares for reported $4976.0 ...
